Continuous Real-time Diagnostics. Automated Glycemic Control.

For patients in hospital or surgery, real-time blood chemistry monitoring and glycemic control are critical. Correcting abnormal glucose levels and keeping them normal speeds recovery, prevents infection, and reduces complications. Early detection of sepsis is crucial to increase the chances of survival. To date, this has been difficult, highly labor-intensive, and imprecise. That is about to change.

iconWatch the video to Learn Moreicon
device
play

About Admetsys

Admetsys has developed a first-of-its-kind real-time diagnostic platform and closed-loop artificial pancreas for hospital and surgical care, leveraging adaptive learning algorithms and counterbalancing treatment of insulin and glucose.

Admetsys has conducted 3 clinical trials in the United States with outstanding results:

ui

97% Control

between 80-125 mg/dL

ui

0% Hypoglycemia

< 70 mg/dL

ui

2.5 hrs Mean Time

to Normoglycemia

test-tube

The first generation product
continuously monitors in real-time:

Remote monitoring available via:

ui remote
iconPhysicians:

Improved blood sugar control has been associated with:

ui

Overall In-Hospital
Mortality

ui
ui

Reduction in
Complications

ui
ui

Reduction in ICU
Length of Stay

ui

Early detection of sepsis has been associated with:

ui

Reduction in average
Length of Stay

ui

Mortality rate
for Sepsis Patients

ui

Cost Avoidance over 1 year
at DeKalb Medical

Source: DeKalb Medical
iconNurses:

Frequent measures are critical for a clear picture
of patient condition.

ui

In one retrospective study, average
frequency was 2.6 hours despite
a goal of hourly checks.

ui

A 12-minute measurement delay (from hourly)
was associated with 67% of severe
hypoglycemia episodes.

nurses

86% of nurses in one study felt that an easier or more automated
form of measurement was needed.

iconAdministrators:

Real-time monitoring and glucose control:

ui

Lowers Legal
& Regulatory Risk

ui

Lowers Costs

ui

Improves
Standard of Care

ui

Improves
Reimbursement Rates

iconInvestors:

The market is in the need of better solution.

ui
$327 Billion – 2017 Estimated Cost of Diabetes in USA
ui

33% Increase over 5 years
(2012 to 2017)

ui

30% of the total medical cost
– hospital inpatient care

Source: American Diabetes Association (ADA), March 2013.
ui
2019 Estimated Cost of Sepsis Care in USA
ui

160% Increase over 6 years
(2013 to 2019)

U.S. Department of Health and Human Services
Published research
  • Insulin-Based Infusion System: Advancing the Development. Journal of Diabetes Science and Technology.
  • Closed-Loop Glucose Control System for In-Hospital Use: Extended Control Trials. American Diabetes Association's 79th Scientific Session.
  • Insulin-Based Infusion System: Preliminary Study. Journal of Diabetes Science and Technology.
  • In-Hospital Stabilisation of Blood-Sugar Control Using an Insulin Balanced Infusion System (Admetsys): Clinical Results from FDA approved Clinical Studies in 43 Diabetes Patients. American Diabetes Association's 76th Scientific Session.
logo
Contact Us

Want to get involved and be a part of Admetsys?
Join us as an Advocate, Advisor or Investor.

Your Message Here...

Message successfully sent.

Close
logo